Veeva Stock Story


USD 225.37  0.72  0.32%   

While some of us are becoming more passionate about healthcare space, it makes sense to focus on Veeva Systems in greater detail. What exactly are Veeva Systems shareholders getting in July? In this post, I will also go over a few different drivers affecting Veeva Systems' products and services, and explain how it may impact Veeva Systems sophisticated investors.
Published over two months ago
View all stories for Veeva Systems | View All Stories

Here is why Veeva Systems (NYSE:VEEV) can still attract sophisticated investors

Veeva Systems's average rating is Buy from 16 analysts.
Macroaxis provides recommendation on Veeva Systems to complement and cross-verify current analyst consensus on Veeva Systems. Our trade recommendation engine determines the firm's potential to grow exclusively from the perspective of an investor's current risk tolerance and investing horizon.

How important is Veeva Systems's Liquidity

Veeva Systems financial leverage refers to using borrowed capital as a funding source to finance Veeva Systems ongoing operations. It is usually used to expand the firm's asset base and generate returns on borrowed capital. Veeva Systems financial leverage is typically calculated by taking the company's all interest-bearing debt and dividing it by total capital. So the higher the debt-to-capital ratio (i.e., financial leverage), the riskier the company. Please check the breakdown between Veeva Systems's total debt and its cash.

What do experts say?

Stock analysis is a method for investors and traders to make buying and selling decisions. By studying and evaluating past and current data, investors and traders attempt to gain an edge in the markets by making informed decisions.
It is good to see analyst projects for Veeva Systems, but it might be worth checking our own buy vs. sell analysis

What is driving Veeva Systems Investor Appetite?

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Veeva Systems has an asset utilization ratio of 262.11 percent. This indicates that the company is making $2.62 for each dollar of assets. An increasing asset utilization means that Veeva Systems is more efficient with each dollar of assets it utilizes for everyday operations.

Will Veeva fall impact its fundamentals?

Latest Information Ratio is up to -0.09. Price may fall again. Veeva Systems exhibits very low volatility with skewness of -0.95 and kurtosis of 4.35. However, we advise investors to further study Veeva Systems technical indicators to make sure all market info is available and is reliable. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Veeva Systems' stock risk against market volatility during both bullying and bearish trends. The higher level of volatility that comes with bear markets can directly impact Veeva Systems' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different stocks as prices fall.

Veeva Systems Implied Volatility

Veeva Systems' implied volatility exposes the market's sentiment of Veeva Systems stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Veeva Systems' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Veeva Systems stock will not fluctuate a lot when Veeva Systems' options are near their expiration.

Our Conclusion on Veeva Systems

While some firms in the health information services industry are either recovering or due for a correction, Veeva Systems may not be performing as strong as the other in terms of long-term growth potentials. To conclude, as of the 31st of May 2022, our analysis shows that Veeva Systems responds to the market. The venture is undervalued and projects close to average chance of financial distress for the next 2 years. Our overall 90 days buy-or-sell advice on the venture is Cautious Hold.

Editorial Staff

This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Gabriel Shpitalnik do not own shares of Veeva Systems. Please refer to our Terms of Use for any information regarding our disclosure principles.

Would you like to provide feedback on the content of this article?

You can get in touch with us directly or send us a quick note via email to